SCM
BIOA

Suvretta Capital Management’s BioAge Labs BIOA Stock Holding History

Suvretta Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,452,336
Closed -$5.46M – 110
2025
Q1 		$5.46M Hold
1,452,336
– – 0.2% 62
2024
Q4 		$8.41M Sell
1,452,336
-2,664
-0.2% -$45.9K 0.29% 59
2024
Q3 		$30.3M Buy
+1,455,000
New +$29.2M 0.97% 38

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Suvretta Capital Management's BIOA Position: Q2 2025 in Review

Suvretta Capital Management sold out of BioAge Labs (BIOA) in Q2 2025, closing a stake of 1,452,336 shares — an estimated $5.46M sold.

Suvretta Capital Management first reported a position in BIOA in Q3 2024 and held it in 3 quarters. The position peaked at $30.3M in Q3 2024. 83 funds tracked by Wall St. Rank hold BIOA as of Q2 2025.

  • Suvretta Capital Management reported no remaining BioAge Labs position as of Q2 2025 after selling out during the quarter.
  • Suvretta Capital Management sold 1,452,336 BioAge Labs shares in Q2 2025, an estimated $5.46M.
  • Suvretta Capital Management first reported a position in BioAge Labs in Q3 2024 and held it in 3 quarters.
  • Suvretta Capital Management's BioAge Labs position peaked at $30.3M in Q3 2024.
  • 83 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2025.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.